Article Details

FDA grants AI-powered ECG screening tool for aortic stenosis its breakthrough device designation

Retrieved on: 2024-10-09 09:01:10

Tags for this article:

Click the tags to see associated articles and topics

FDA grants AI-powered ECG screening tool for aortic stenosis its breakthrough device designation. View article details on hiswai:

Summary

The article discusses AccurKardia's FDA breakthrough device designation for AI-based software that screens ECGs for aortic stenosis, showcasing a significant advancement in healthcare technology, especially in cardiology and electrodiagnosis related to heart and organ failure.

Article found on: cardiovascularbusiness.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up